EVALECGcardio Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 750 participants.

Also called NCT04468477

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 750 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04468477
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04468477. Non-randomized; no masking; primary purpose diagnostic. Start 2020-05-29 (actual); primary completion 2021-05-21 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EVALECGcardio Study
Condition
Cardiac Arrhythmia
Intervention (Device)
6 Lead ECG
Lead sponsor
The Leeds Teaching Hospitals NHS Trust (class: other)

Record details

Record id
cardio:ct-nct04468477
Content hash
0522b273abcd45e9066727052140076c14cd8588a7780b4a6a811f83ef56d1c6